← Back to Directory

Aeolus Pharmaceuticals, Inc. (AOLS) - Latest Market Data

Track the most recent price, market cap, volume, and performance data for Aeolus Pharmaceuticals, Inc. (AOLS).

Get it on Google Play Download on Google Play Download on the App Store Download on the App Store

Equity Details

Price & Market Data

Price: $0.0₃1

Daily Change: $0.00 / 0.00%

Daily Range: $0 - $0

Market Cap: $15,209

Daily Volume: 0

About Aeolus Pharmaceuticals, Inc. (AOLS)

A complete picture of Aeolus Pharmaceuticals, Inc. (AOLS). Price: 0.0₃1, daily change: $0.00 / 0.00%. Market cap: 15,209. All key performance data is updated.

Details

Aeolus Pharmaceuticals, Inc., a biopharmaceutical company, develops a platform of novel compounds for use in biodefense, fibrosis, oncology, infectious, and central nervous system diseases in the United States. The company develops a class of catalytic antioxidant compounds as medical countermeasures against nuclear, radiological, and chemical weapons, as well as for diseases and disorders of the respiratory system, central nervous system, and oncology. Its lead compound includes AEOL 10150 that has completed two Phase I clinical trials, which is developed against the pulmonary sub-syndrome of acute radiation syndrome; and for use as a medical countermeasure for exposure to chemical vesicants and nerve agents. The company is also developing AEOL 11207 for the treatment of Parkinson's disease. Aeolus Pharmaceuticals, Inc. was founded in 1994 and is based in Mission Viejo, California.

Selected stocks

CT Real Estate Invt Tr (CTRRF)

Rafina Innovations Inc. (VICA)

Senvest Capital Inc. (SVCTF)

Toyota Motor Corp. (TOYOF)

4DS Memory Ltd. (FRDSF)